MSTVIM
ABEO icon

Messner & Smith Theme Value Investment Management’s Abeona Therapeutics ABEO Stock Holding History

Messner & Smith Theme Value Investment Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-4
Closed – – 79
2014
Q4 		$0 Buy
+4
New +$359 ﹤0.01% 68

Other funds holding ABEO

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Messner & Smith Theme Value Investment Management's ABEO Position: Q1 2015 in Review

Messner & Smith Theme Value Investment Management sold out of Abeona Therapeutics (ABEO) in Q1 2015, closing a stake of 4 shares.

Messner & Smith Theme Value Investment Management first reported a position in ABEO in Q4 2014 and held it in 1 quarter. The position peaked at $0 in Q4 2014. 12 funds tracked by Wall St. Rank hold ABEO as of Q1 2015.

  • Messner & Smith Theme Value Investment Management reported no remaining Abeona Therapeutics position as of Q1 2015 after selling out during the quarter.
  • Messner & Smith Theme Value Investment Management sold 4 Abeona Therapeutics shares in Q1 2015.
  • Messner & Smith Theme Value Investment Management first reported a position in Abeona Therapeutics in Q4 2014 and held it in 1 quarter.
  • Messner & Smith Theme Value Investment Management's Abeona Therapeutics position peaked at $0 in Q4 2014.
  • 12 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2015.

Based on Messner & Smith Theme Value Investment Management's 13F filing for Q1 2015, filed 7 May 2015.